Superion IDS Interspinous Distraction System

· Boston Scientific Corporation

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Superion IDS Interspinous Distraction System, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A 5-year Superion™ IDS Clinical Outcomes Post-Approval Evaluation (SCOPE) [NA]